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ABSTRACT
The emergingMiddle East respiratory syndrome coronavirus (MERS-CoV) causes lethal respiratory infections mainly on the
Arabian Peninsula. The evolutionary origins of MERS-CoV are unknown.We determined the full genome sequence of a CoV
directly from fecal material obtained from a South AfricanNeoromicia capensis bat (NeoCoV). NeoCoV shared essential details
of genome architecture withMERS-CoV. Eighty-five percent of the NeoCoV genome was identical to MERS-CoV at the nucleo-
tide level. Based on taxonomic criteria, NeoCoV andMERS-CoV belonged to one viral species. The presence of a genetically di-
vergent S1 subunit within the NeoCoV spike gene indicated that intraspike recombination events may have been involved in the
emergence of MERS-CoV. NeoCoV constitutes a sister taxon of MERS-CoV, placing theMERS-CoV root between a recently de-
scribed virus from African camels and all other viruses. This suggests a higher level of viral diversity in camels than in humans.
Together with serologic evidence for widespreadMERS-CoV infection in camelids sampled up to 20 years ago in Africa and the
Arabian Peninsula, the genetic data indicate that camels act as sources of virus for humans rather than vice versa. The majority
of camels on the Arabian Peninsula is imported from the Greater Horn of Africa, where severalNeoromicia species occur. The
acquisition of MERS-CoV by camels from bats might have taken place in sub-Saharan Africa. Camelids may represent mixing
vessels for MERS-CoV and other mammalian CoVs.
IMPORTANCE
It is unclear how, when, and where the highly pathogenic MERS-CoV emerged.We characterized the full genome of an African
bat virus closely related toMERS-CoV and show that human, camel, and bat viruses belong to the same viral species. The bat
virus roots the phylogenetic tree of MERS-CoV, providing evidence for an evolution of MERS-CoV in camels that preceded that
in humans. The revised tree suggests that humans are infected by camels rather than vice versa. AlthoughMERS-CoV cases occur
mainly on the Arabian Peninsula, the data from this study together with serologic andmolecular investigations of African cam-
els indicate that the initial host switch from bats may have taken place in Africa. The emergence of MERS-CoV likely involved
exchanges of genetic elements between different viral ancestors. These exchanges may have taken place either in bat ancestors or
in camels acting as mixing vessels for viruses from different hosts.
Human coronaviruses (HCoVs) belong to the genera Alphac-oronavirus and Betacoronavirus within the subfamily Corona-
virinae. Betacoronaviruses are further divided into four genetic
clades, termed clades a to d (1). The genetic diversity of CoVs in
bats exceeds that known for any other host, which is compatible
with bats being the major reservoir of mammalian CoVs (2).
In 2002 to 2003, an emerging HCoV, termed severe acute re-
spiratory syndrome coronavirus (SARS-CoV), caused a pandemic
involving about 8,000 cases, about 10% of whom died. SARS-CoV
belonged to Betacoronavirus clade b. The evolutionary origins of
SARS-CoV involved bat hosts, possibly with civets as intermediate
hosts and the source of human infection (3, 4).
In 2012, a novel HCoV, termed Middle East respiratory syn-
drome CoV (MERS-CoV), was detected in a patient with a fatal
respiratory infection in Saudi Arabia (5). As of 11 June 2014,
MERS-CoV infection has been diagnosed in 699 patients, mainly
from the Arabian Peninsula, with a case fatality rate potentially
exceeding the rate observed during the SARS pandemic (6). Be-
cause camels on the Arabian Peninsula show high rates of neutral-
izing antibodies against MERS-CoV and harbor viruses that are
genetically highly related to those from human cases, these ani-
mals are considered to constitute the source of human infections
(7–9). High rates of antibodies against MERS-CoV were recently
found in African camels, and a MERS-CoV strain was detected in
an Egyptian camel likely imported from Sudan (10–12).
MERS-CoV belongs to Betacoronavirus clade c (13, 14). The
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prototype clade c betacoronaviruses, termed HKU4 and HKU5,
were detected in bats (15). HKU4 and HKU5 form two separate
species in genetic sister relationship to MERS-CoV (13). Distinct
clade c betacoronaviruses putatively representing another clade c
Betacoronavirus species (Erinaceus CoV [EriCoV]) were recently
described in hedgehogs (16). We and others characterized small
genomic sequence fragments of bat CoVs (BtCoVs) that were
closely related to MERS-CoV and suggested that MERS-CoV an-
cestors may have evolved in bats (17–19). Because these sequence
fragments encompassed only a few hundred nucleotides from a
single gene, theRNA-dependent RNA polymerase (RdRp) gene, the
evolutionary relationship of these bat CoVs with MERS-CoV
could not be conclusively defined (20, 21). A bat virus most likely
representing a potential MERS-CoV ancestor was detected in a
Neoromicia capensis bat from South Africa (22).
In this study, we characterized the full genome of the Neoromi-
cia bat CoV, referred to here as NeoCoV. We determined that
NeoCoV belongs to the same viral species defined by MERS-CoV
based upon established taxonomic criteria (1, 21). Analysis of the
NeoCoV genome pointed toward nonrecent recombination
events within the MERS-CoV species. The bat virus roots the phy-
logenetic tree of MERS-CoV and shows that MERS-CoV evolu-
tion in camelids likely preceded that in humans.
MATERIALS AND METHODS
Sample processing and full-genome sequencing. A fecal specimen from
a Neoromicia bat from South Africa was sampled and tested positive for
CoVs, as described previously (22). To obtain the full sequence of the
NeoCoV genome, 70 heminested reverse transcription-PCR (RT-PCR)
assays were developed (primer sequences and PCR conditions are listed in
Table S1 in the supplemental material). These assays were designed to
amplify about 800 overlapping base pairs of all known MERS-CoV se-
quences.
Genomic fragments that could not be amplified by these assays were
connected by bridging RT-PCR using NeoCoV-specific primers (available
upon request) and sequenced by dye terminator chemistry. Determina-
tion of genome ends was done by using a rapid amplification of cDNA
ends kit (Roche, Penzberg, Germany).
Genomic analyses.Nucleotide and amino acid sequences of predicted
open reading frames (ORFs) and the full genome of NeoCoV and related
betacoronaviruses were aligned by using MAFFT (23). The pairwise iden-
tities of the genome and all ORFs and predicted proteins of NeoCoV were
calculated by using MEGA5 (24). Similarity plots of CoV clade c genomes
were generated by using SSE v1.1 (25), using a sliding window of 400 and
a step size of 40 nucleotides (nt). Phylogenetic analyses of predicted ORFs
were done by using MrBayes v3.1 (26), using a GTRGI nucleotide or
a WAG amino acid substitution model and 2,000,000 generations sam-
pled every 100 steps. Trees were annotated by using the latter 75% of all
trees in TreeAnnotator v1.5 and visualized with FigTree v1.4 from the
BEAST package (27).
RESULTS AND DISCUSSION
The NeoCoV-positive bat was identified as a female Neoromicia
capensis (shown in Fig. 1) based on size (forearm length of 35 mm
and mass of 5.5 g) and dental and cranial characteristics (28).
Typing was confirmed by characterization of the cytochrome b
and cytochrome oxidase I (COI) genes (GenBank accession num-
bers KJ756000 and KJ756001), allowing definite species identifi-
cation as N. capensis.
The full NeoCoV genome sequence was obtained directly from
fecal material stored in RNAlater by using the panel of PCR assays
developed for this study as well as NeoCoV-specific primers. This
suggests an applicability of this panel for characterizations of ge-
netically diversified MERS-CoVs in further studies. Figure 2A
shows a graphical representation of the NeoCoV genome (Gen-
Bank accession number KC869678). This genome contained
30,100 nt excluding the poly(A) tail, with a G/C content of 40%.
This was comparable to MERS-CoV strains, which range in size
from 30,100 to 30,107 nt and have a G/C content of 41%. The
number and order of NeoCoV open reading frames (ORFs) were
identical to those of MERS-CoV in the order ORF1ab-spike-
ORF3-ORF4ab-ORF5-envelope (E)-membrane (M)-nucleocapsid
(N)-ORF8b. As in MERS-CoV, a ribosomal frameshift site and 16
nonstructural protein (NSP) domains within ORF1ab were pre-
dicted. Table 1 provides information on the size and genomic
location of these NSP domains.
Figure 2A and Table 2 provide details on the predicted ORFs,
transcription regulatory sequences (TRSs), and their genomic lo-
calizations. In analogy to MERS-CoV, eight putative TRSs with
the conserved TRS core motif of clade c betacoronaviruses, AAC
GAA, preceded predicted ORFs. The predicted leader TRS core
sequence of NeoCoV (TTAACGAACT) and the predicted body
TRS core sequences of NeoCoV were completely identical to those
of MERS-CoVs. This included TRS core sequences preceding the
E (AAAACGAACT) and N (TTAACGAATC) genes showing mi-
nor sequence differences, as observed previously for MERS-CoV
(13). As in MERS-CoV, no separate body TRSs preceding the pre-
dicted AUG codons of ORF4b and ORF8b were detected.
Amino acid sequence identity in seven concatenated NSP do-
mains has been established by the International Committee on
Taxonomy of Viruses (ICTV) for CoV species demarcation (1,
21). As shown in Table 3, the amino acid sequence identity of these
translated domains of NeoCoV was 97.2 to 97.4% compared to
MERS-CoV strains. Because this exceeded the 90% threshold de-
fined to separate CoV species (1), NeoCoV and MERS-CoV be-
FIG1 Neoromicia capensis bat. The absence of a tiny upper premolar separates
it from similarly sized Pipistrellus and Hypsugo bats. The presence of an occip-
ital helmet separates it from Neoromicia zuluensis, the species to which it was
assigned based on preliminary morphological criteria.
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longed to the same species. The established Betacoronavirus clade
c species HKU4 and HKU5 and hedgehog CoV shared 85.3 to
88.7% amino acid sequence identity with MERS-CoVs from hu-
mans and camels as well as NeoCoV, substantiating the classifica-
tion of MERS-CoV as a separate species.
To analyze the relationships of NeoCoV with MERS-CoV and
other clade c betacoronaviruses beyond the domains used for spe-
cies delineation, full-genome comparisons were made. NeoCoV
shared 85.5% to 85.6% overall nucleotide identity with MERS-
CoVs from humans and camels. Nucleotide identity with other
clade c betacoronaviruses was considerably lower, at 25.5 to
51.5%. Figure 2B shows that the nucleotide identity between
NeoCoV and MERS-CoV decreased in the genomic region encod-
ing the spike glycoprotein. Sequence identity was lower toward the
5= end of the spikeORF than toward its 3= end. The translated spike
ORF of NeoCoV showed 64.3 to 64.6% identity with MERS-CoV
and 60.5 to 63.6% identity with other clade c betacoronaviruses.
Table 2 shows that the amino acid sequence identities between
NeoCoV and MERS-CoV were higher for all other ORFs. The
genes encoding the structural proteins E, M, and N showed high
levels of sequence identity between NeoCoV and MERS-CoV
strains, up to 89.0% (E), 94.5% (M) and 91.7% (N). The functions
of MERS-CoV ORF3, ORF4ab, ORF5, and ORF8b are poorly un-
derstood. Sequence identities between these ORFs from NeoCoV
and those from MERS-CoV ranged between 76.5% (ORF3) and
88.4% (ORF5). These identity levels exceed those between any
other clade c betacoronavirus and MERS-CoV by 2- to 3-fold.
This includes ORF4a, which acts as an interferon antagonist, pre-
sumably by interaction with double-stranded RNA in MERS-CoV
(29). The 23 amino acid (aa) positions suggested to form a double-
stranded RNA-binding domain in the MERS-CoV 4a protein (29)
were completely conserved in NeoCoV, suggesting that the pre-
dicted NeoCoV protein might have a homologous function.
To confirm the genetic relationships suggested by sequence
distance comparisons, Bayesian phylogenies of major ORFs were
reconstructed. As shown in Fig. 3A, NeoCoV clustered with a basal
sister relationship to a clade containing MERS-CoV from humans
and camels in all ORFs except the spike ORF. In the spike ORF,
NeoCoV clustered with European hedgehog CoVs and a Nycteris
bat CoV from Ghana. To find reasons for the variant tree topology
in the spike ORF, Bayesian phylogenetic reconstructions and se-
quence distance analyses were done on two different spike ORF
data sets. One data set represented subunit S1, which contains the
receptor-binding domain (RBD). Another data set represented
subunit S2, involved in the fusion of viral and cellular membranes.
Figure 3B shows that in the phylogenetic tree of the S1 subunit,
NeoCoV clustered distantly from MERS-CoV at the same position
as that observed in the tree based on the full spike sequence. Ac-
cordingly, MERS-CoV and NeoCoV showed only 46.0% amino
acid sequence identity in the S1 subunit. In the S2 subunit, Neo-
CoV shared a monophyletic origin with MERS-CoV in a basal
sister relationship to MERS-CoVs from humans and camels, sim-
ilar to the phylogenetic reconstructions in all other ORFs. Mono-
phyly correlated with a higher degree of amino acid sequence
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FIG 2 Genome organization of NeoCoV and sequence identity compared to
other clade c betacoronaviruses. (A) Genome organization of NeoCoV. The
NeoCoV genome is represented by a black line; ORFs are indicated by gray
arrows. The ribosomal frameshift site (RFS) is marked with an arrowhead. The
locations of transcription regulatory core sequences (TRSs) following the
leader (L) are marked by labeled dots and numbered in their order of appear-
ance from the genomic 5= terminus. (B) Genomic sequence identity between
NeoCoV and other clade c betacoronaviruses. Plots were generated by using
SSE version 1.1 (25). The graph representing the comparison of the phyloge-
netically basal camel virus NRCE-HKU205 and NeoCoV is not shown due to a
total overlap in the curve resulting from the comparison between NeoCoV and
human MERS-CoV. TABLE 1 Prediction of the putative pp1a/pp1ab cleavage sites of
NeoCoV based on sequence comparison with MERS-CoV strain EMC/
2012
NSP
1st amino acid
residue-last amino
acid residuea
Protein size
(no. of
amino
acids)
Putative functional
domain(s)b
NSP1 Met1-Gly193 193
NSP2 Asp194-Gly857 664
NSP3 Ala858-Gly2743 1,886 ADRP, PL2pro
NSP4 Ala2744-Gln3250 507
NSP5 Ser3251-Gln3556 306 3CLpro
NSP6 Ser3557-Gln3848 292
NSP7 Ser3849-Gln3931 83
NSP8 Ala3932-Gln4130 198 Primase
NSP9 Asn4131-Gln4240 110
NSP10 Ala4241-Gln4380 140
NSP11 Ser4381-Leu4394 14 Short peptide at the
end of ORF1a
NSP12 Ser4381-Gln5314 933 RdRp
NSP13 Ala5315-Gln5912 598 HEL, NTPase
NSP14 Ser5913-Gln6436 524 ExoN, NMT
NSP15 Gly6437-Gln6779 343 NendoU
NSP16 Ala6780-Arg7082 303 OMT
a Superscript numbers indicate positions in polyprotein pp1a/pp1ab or positions in the
available sequence with the supposition of a ribosomal frameshift based on the
conserved slippery sequence (UUUAAAC) of coronaviruses.
b ADRP, ADP-ribose 1-phosphatase; PL2pro, papain-like protease 2; 3CLpro,
coronavirus NSP5 protease; Hel, helicase; NTPase, nucleoside triphosphatase; ExoN,
exoribonuclease; NMT, N7 methyltransferase; NendoU, endoribonuclease; OMT,
2=-O-methyltransferase.
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identity (87.2%) between MERS-CoV and NeoCoV in the S2 sub-
unit.
These data suggested that the human-pathogenic MERS-CoV
variant might be the result of nonrecent recombination events
involving as-yet-unknown partners. Typical recombination
breakpoints in CoV genomes encompass the spike gene (2). In-
traspike recombination between the S1 and S2 subunits has been
hypothesized to be the major mechanism involved in the emer-
gence of SARS-CoV from bat and civet ancestors (30). The loca-
tion of RBDs at either the N or the C termini of the S1 subunits of
HCoV-229E and mouse hepatitis virus (MHV) has been inter-
preted as further evidence for the interchangeability of spike sub-
units (30).
The different S1 subunit suggested that NeoCoV was not the
direct ancestor of MERS-CoV. Of note, CoVs are mostly associ-
ated with chiropteran hosts on the genus level (2), and MERS-
CoV was shown to infect cells from vespertilionid bats (31). Ac-
cording to this principle, MERS-CoV variants carrying a spike
gene closely related to human-pathogenic MERS-CoV may exist
in bats belonging to the familyVespertilionidae and specifically the
genus Neoromicia. This scenario parallels the spike gene diversity
found in bat CoV ancestors of SARS-CoV. All ancestral bat SARS-
related CoVs described since 2005 have had highly diversified
spike genes, which differed from human SARS-CoV by about 20%
of their amino acid sequences (4). Only recently, a bat virus car-
rying a spike gene related to human SARS-CoV and capable of
using the SARS-CoV receptor molecule ACE2 was found (3). In
agreement with the principle that chiropteran hosts can harbor
closely related CoVs, the bat CoV carrying the human SARS-CoV-
related spike gene occurred in Rhinolophus sinicus, which is the
same bat species yielding multiple SARS-related CoV lineages car-
rying divergent spike genes since 2005 (2).
Because NeoCoV clustered with a basal sister relationship to
MERS-CoV in all ORFs and because NeoCoV and MERS-CoV
belonged to one virus species, the bat virus can be used to infer the
root of the phylogenetic tree of MERS-CoV. Figure 3C shows a
Bayesian phylogenetic reconstruction of all available MERS-CoV
full genomes from camels and representative MERS-CoV full ge-
nomes from humans, rooted by NeoCoV. The MERS-CoV de-
tected in an African camel, termed NRCE-HKU205 (10), clus-
tered with high statistical support in basal sister relationship to
MERS-CoVs from humans and camels from the Arabian Penin-
sula. Despite the phylogenetic clustering of NRCE-HKU205 in an
intermediate position between NeoCoV and MERS-CoVs from
the Arabian Peninsula, the maximum nucleotide distance of
NeoCoV and NRCE-HKU205 did not differ from the maximum
nucleotide distance of NeoCoV and the other MERS-CoVs, at
14.5% and 14.4 to 14.5%, respectively. The maximum nucleotide
distance within MERS-CoVs from camels was 0.6%. This was
slightly higher than the 0.4% maximum distance within MERS-
CoVs from humans, although only 11 near-full-length genomes
are available for MERS-CoVs from camels, compared to 38 near-
full-length genomes for MERS-CoVs from humans.
The absence of more diversified MERS-CoV sequences in hu-
mans, particularly outside the Arabian Peninsula, cannot be fully
TABLE 3 Comparison of amino acid identities of seven conserved
replicase domains of NeoCoV for species classification
BtCoV/Neoromicia/
PML-PHE1/RSA/2011
domain
% amino acid identity witha:
MERS-CoVb HKU4c HKU5d EriCoVe
ADRP 90.6 59.1–60.4 63.1 67.5
NSP5 (3CLpro) 96.4–97.1 80.4–80.7 82.4–83.0 78.4–79.1
NSP12 (RdRp) 98.6–98.7 89.9–90.0 92.5 89.1–89.5
NSP13 (Hel, NTPase) 98.5–98.7 91.8–92.3 94.5 91.0–91.1
NSP14 (ExoN, NMT) 97.9–98.3 85.7–86.6 91.8–92.0 89.1–89.5
NSP15 (NendoU) 93.6–94.5 77.2–77.8 81.9–82.2 81.9–82.5
NSP16 (OMT) 96.4 83.4 87.1 86.8–87.8
Concatenated domains 97.2–97.4 85.3–85.4 88.7 86.5
a Calculated with MEGA5 (24) using a pairwise deletion option.
b Including GenBank accession numbers JX869059, KC164505, KC776174, KF186567,
KF192507, KF600612, KF600620, and KJ477102.
c Including GenBank accession numbers EF065506, EF065507, EF065508, and
DQ648794.
d Including GenBank accession numbers EF065505, EF065509, EF065510, EF065511,
and EF065512.
e Including GenBank accession numbers KC545383 and KC545386.
TABLE 2 Coding potential, putative transcription regulatory sequences, and sequence comparison with prototype clade c betacoronaviruses
ORF
nt positions
(start-end)
No. of
amino acids Sequencea
% amino acid identityb of BtCoV/Neoromicia/PML-PHE1/
RSA/2011 with:
MERS-CoVc HKU4d HKU5e EriCoVf
ORF 1ab 281–21528 7,082 00057GATCTTAACGAACTTAAA74 92.7 73.7 76.0 73.9
Spike 21470–25504 1,344 21412CAGATTAACGAACTTGTA21429 64.3–64.6 60.5–60.8 61.5 63.6
ORF3 25519–25830 103 25501CTAATTAACGAACTTCCA25518 76.5–78.4 40.7–44.0 47.9 27.3–28.4
ORF4a 25839–26168 109 25823TTAATTAACGAACTCTAT25840 87.0–88.0 37.4–38.3 41.9–42.9 40.7
ORF4b 26044–26820 258 83.7–85.4 28.6–29.4 26.8–26.8 39.0
ORF5 26827–27501 224 26813GATTTTAACGAACTATGG26830 87.1–88.4 47.1 54.8–55.7 51.3
E 27577–27825 82 27563ATGGAAAACGAACTATGT27580 89.0 73.2–74.4 72.0 76.8
M 27840–28499 219 27818GGGTTTAACGAACTCCTT27835 93.6–94.5 81.7–82.2 82.6–83.1 80.7–81.2
N 28557–29801 414 28528GATCTTAACGAATCTTAA28545 91.3–91.7 76.5–76.8 76.0 72.7–73.0
ORF8b 28603–29202 199 81.1–83.9 48.7–50.8 52.6–55.8 45.4–46.4
a Underlined type indicates conserved nucleotides of the putative leader TRS core sequence. Subscripted numbers indicate positions in the BtCoV/Neoromicia/PML-PHE1/RSA/
2011 genome.
b Calculated with MEGA5 (24) using a pairwise deletion option.
c GenBank accession numbers JX869059, KC164505, KC776174, KF186567, KF192507, KF600612, KF600620, and KJ477102.
d GenBank accession numbers EF065506, EF065507, EF065508, and DQ648794.
e GenBank accession numbers EF065505, EF065509, EF065510, EF065511, and EF065512.
f GenBank accession numbers KC545383 and KC545386.
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excluded. However, the phylogenetic position of the outlier camel
MERS-CoV and the slightly higher level of genetic diversity in
camels suggest that the evolution of MERS-CoV in camels pre-
ceded that in humans and that camels represent donors of viruses
for humans rather than vice versa. These genetic data are corrob-
orated by the existence of specific antibodies against MERS-CoV
in up to 90% of camelids from the Arabian Peninsula and Africa
for at least 20 years (7, 9, 11, 12). On the contrary, sera from
children with respiratory disease sampled in 2010 to 2011 in Saudi
Arabia (32) and sera from blood donors and slaughterhouse
workers sampled in Saudi Arabia in 2012 (33) showed no evidence
of antibodies against MERS-CoV.
Interestingly, the camel yielding the genetic outlier MERS-
CoV was likely imported from Sudan into Egypt (10). The major-
ity of camels in the Arabian Peninsula are imported from coun-
tries in the Greater Horn of Africa, such as Somalia, Sudan, and
Kenya (10, 11). We and others have recently shown that MERS-
CoV-neutralizing antibodies occur frequently in camels from
eastern Africa (11, 12). A hypothetical scenario might thus imply a
spillover of viruses from bats to camels in the Greater Horn of
Africa. Of note, 10 out of 11 Neoromicia species listed by the In-
ternational Union for Conservation of Nature (http://www
.iucnredlist.org/), including N. capensis, are common in this re-
gion. An alternative scenario implying an exchange of viruses
between Neoromicia bats and camels on the Arabian Peninsula is
unlikely, because Neoromicia bats are not known to occur in this
region.
The deep branches leading to NeoCoV in phylogenetic recon-
structions and the differences observed in the spike gene of this bat
virus suggest that this putative host switch may have occurred
nonrecently. Although NeoCoV formed one viral species together
with MERS-CoVs from humans and camels, unidirectional host
switching events from bat hosts to other mammalian hosts such as
camels and different evolutionary histories in these hosts can be
assumed. The bat, camel, and human hosts of this CoV species are
thus unlikely to fulfill the population criteria required for coales-
cent dating. Additionally, dating of CoV branches deeper than
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FIG 3 Bayesian phylogenies of clade c betacoronaviruses, including NeoCoV.
(A) Phylogenies of ORF1a, ORF1b, and ORFs coding for structural proteins.
(B) Phylogenies of the S1 and S2 subunits, corresponding to amino acid posi-
tions 1 to 747 and 748 to 1353, respectively, of MERS-CoV strain EMC/2012.
NeoCoV is shown in red, camel MERS-CoV is shown in blue, and human
MERS-CoV is shown in cyan. HCoV-OC43 was used as an outgroup. (C)
Phylogeny of MERS-CoV full genomes. MERS-CoVs obtained from humans
are shown in black, and MERS-CoVs from camels are shown in blue. NeoCoV
was used for rooting the tree. For all trees, statistical support of grouping from
Bayesian posterior probabilities is shown at deep nodes. Only values above 0.7
are shown. The bar represents genetic distance. GenBank accession numbers
are KJ477102 for NRCE-HKU205, KJ156881 for Wadi-Ad-Dawasir 1 2013,
JX869059 for EMC/2012, KJ650296 for KFU-HKU19D, KC776174 for Jordan-
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174, and KM027259 for Jeddah 2014 C9055.
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0.05 substitutions per site, such as those leading to the predicted
ancestor of NeoCoV and MERS-CoV, was found to be highly un-
reliable and may greatly underestimate the true evolutionary his-
tory of CoVs (34). Therefore, and because of the evidence for
recombination detected in the NeoCoV spike gene, no molecular
dating of the projected ancestor shared by NeoCoV and other
MERS-CoVs was conducted.
The putative ancient recombination events giving rise to
MERS-CoV may have taken place in two candidate hosts to be
explored. The first and more likely option is vespertilionid bats. It
would be highly relevant to fully characterize additional bat vi-
ruses from Africa and the Arabian Peninsula. Alternatively, cam-
elids may represent a putative mixing vessel, similar to the role of
swine in influenza A viruses (35). Sera from camelids should be
tested for antibodies against the NeoCoV S1 subunit to gather
evidence for infection with this CoV lineage. In parallel, camelids
should be screened to identify genetically diversified viruses po-
tentially related to their putative bat ancestors. The putative role of
camelids as recipients of CoVs from other mammalian hosts is
supported by the occurrence of viruses in camelids that are closely
related to human CoV-229E and bovine CoV (36, 37).
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